PROTHROMPLEX TOTAL NF 500IU Prášek a rozpouštědlo pro injekční roztok Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

prothromplex total nf 500iu prášek a rozpouštědlo pro injekční roztok

baxalta innovations gmbh, vídeň array - 3532 protrombin; 3534 lidskÝ koagulaČnÍ faktor vii; 1990 lidskÝ koagulaČnÍ faktor ix; 2218 lidskÝ koagulaČnÍ faktor x; 15686 protein c - prášek a rozpouštědlo pro injekční roztok - 500iu - kombinace koagulaČnÍch faktorŮ ix, ii, vii a x

CYMVIGO 100U/ML Infuzní roztok Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

cymvigo 100u/ml infuzní roztok

biotest pharma gmbh, dreieich array - 16576 lidskÝ plazmatickÝ protein - infuzní roztok - 100u/ml - imunoglobulin proti cytomegaloviru

Prevexxion RN+HVT+IBD Evropská unie - čeština - EMA (European Medicines Agency)

prevexxion rn+hvt+ibd

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kuře - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Sapropterin Dipharma Evropská unie - čeština - EMA (European Medicines Agency)

sapropterin dipharma

dipharma arzneimittel gmbh - sapropterin-dihydrochloridu - fenylketonurie - jiné zažívací trakt a produkty metabolismu, - sapropterin dipharma is indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with phenylketonuria (pku) who have been shown to be responsive to such treatment. sapropterin dipharma is also indicated for the treatment of hyperphenylalaninaemia (hpa) in adults and paediatric patients of all ages with tetrahydrobiopterin (bh4) deficiency who have been shown to be responsive to such treatment.